We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The Promise of In Vitro 3D Organoid Models: Meeting the ADME-Tox Testing Needs of the Pharmaceutical Industry

Article   Nov 11, 2019 | by Maureen Bunger, Product Manager ADME-Tox solutions, Lonza

 
The Promise of <i>In Vitro</i> 3D Organoid Models: Meeting the ADME-Tox Testing Needs of the Pharmaceutical Industry

Source: Sebastian Kaulitzki/Shutterstock

 
 
 

RELATED ARTICLES

What is Pharmacovigilance?

Article

Pharmaceutical drugs are a valuable part of patient care throughout the world. For doctors to adequately care for their patients, drug safety must be monitored and reported from initial testing to everyday use. In this article, we explore the world of pharmacovigilance.

READ MORE

Future Cancer Immunotherapy Treatments Could Be Administered by a Pill

Article

Immunotherapies delivered in pill form aren’t yet the default cancer treatment. Techniques like protein painting are bringing that day closer.

READ MORE

Cell Culture Workflows In a Spin? How Next-generation Centrifuges Are Overcoming Common Challenges

Article

Benchtop centrifuges are the workhorse of cell culture laboratories, and are used across a wide range of applications. However, when employing conventional benchtop systems, scientists can encounter a set of challenges that can put the integrity, productivity and reproducibility of their workflows at risk. In this article, we discuss these issues and explain how the latest technological advances are helping laboratories to overcome them, allowing organizations to improve efficiency and achieve more reliable results.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE